RECENT COMMENTS

Jose Gros-Aymerich, MD: This is a relapsing-remitting subject. Not long ago, another TKI got EMEA approval for pancreatic ca [...]   »Read more

Richard: Excellent article, but the danger of focussing on one success story is that we can't see the bigger [...]   »Read more

Rajesh Kumar: Is it helpfull for Overian cancer patient at advance stage? Rajesh Kumar +919681303310   »Read more

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

 

Article type: Newsround

Keywords: colorectal cancer, medulloblastoma, exercise, prostate cancer, ovarian cancer, lung cancer, .

This article has 2 comments

Facebook Twitter Share - Send - Print - Pdf

 

NEWSROUND

Selected press reports complied by the ESO Cancer Media Centre


To read the complete article please click on the pdf icon
 
COMMENTS (2)
 
Rajesh Kumar says: 23 January 2012 10:09:23
Please write your comment here
 
Rajesh Kumar says: 23 January 2012 10:14:19
+919681303310.
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.

ESO reserves the absolute right not to publish comments.
  Name (required)
  E-mail (will not be published) (required)
  Captcha code (required)

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
ECPC
ECPC
Europa Donna
Europa
Donna
Europa Uomo
Europa
Uomo
EONS
EONS
SIOG
SIOG
The challenge Fund
The
Challenge
Fund
Seno network
SenoNetwork
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.